Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo

Figure 1

Inhibition of bladder cancer cell proliferation by belinostat at 1, 2 and 5 μM for 48 h in the human urinary bladder cancer cell lines 5637, T24, J82 and RT4. Percent inhibition from control was determined using the WST-1 tetrazolium salt cleavage assay. Bars are representative of at least 3 independent experiments and are the mean of at least 8 wells per condition. Error bars indicate SEM.

Back to article page